Ingram, J. R., Porter, M., Chovatiya, R., Giamarellos-Bourboulis, E. J., Bechara, F. G., Fujita, H., Gulliver, W., Muller, E., Bari, M., Rolleri, R., Byerly, R. and Kirby, J. S. (2024) “Bimekizumab Response Maintenance to 48 Weeks in Patients with Moderate to Severe Hidradenitis Suppurativa: Pooled Responder Analysis from the Phase 3, Double-Blind, Placebo-Controlled, Randomized Clinical Trials BE HEARD I and II”, SKIN The Journal of Cutaneous Medicine, 8(2), p. s396. doi: 10.25251/skin.8.supp.396.